M4MM

Aurora Cannabis Reports Q4 2024 Financial Results

LOS ANGELES- Aurora Cannabis Inc. a Canada-based medical-focused cannabis company, has announced its financial results for the fourth quarter of fiscal 2024. The company reported revenue of $55.9 million, marking a 5% increase from $53.2 ...

  • Panaxia Pharmaceutical Industries

Panaxia Continues Growth

LOD, Israel -- Panaxia Labs Israel Ltd., (TASE: PNAX), a pharma company that develops, manufactures and markets progressive medical cannabis products in pharmaceutical quality, published its financial reports for the second quarter and first half ...

France Medical Cannabis Patient Program Gets Underway

EDMONTON, AB– Aurora Germany GmbH, a subsidiary of Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, and Ethypharm, have successfully delivered their initial shipment of cannabis to the ...

Greenlane Shareholders Vote to Approve Merger with KushCo

BOCA RATON–Greenlane Holdings, Inc. (Nasdaq: GNLN), a global house of brands and one of the largest sellers of premium cannabis accessories, child-resistant packaging, and specialty vaporization products, today announced that its stockholders have approved the ...

Subscribe To Our Newsletter